BridgeBio Oncology Therapeutics Inc.
BBOT | NASDAQ
$4.67
+$0.01 (+0.21%)
Sep 22, 2026, 10:37 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q4 2022 Dec 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 186K | 186K | n/a | n/a | 156K | 156K | 156K | 156K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -186K | -186K | n/a | n/a | -156K | -156K | -156K | -156K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -198.96M | -168.86M | -145.82M | -124.29M | -94.77M | -88.55M | -80.86M | -59.03M | -39.36M | -15.49M | -41.69K | -3.52K | -3.52K |
Interest Income | 15.36M | 13.89M | 11.75M | 9.58M | 8.69M | 9.06M | 8.46M | 6.21M | 3.65M | 1.21M | n/a | n/a | n/a |
Pretax Income | -182.11M | -154.1M | -134.04M | -114.93M | -87.5M | -80.89M | -74.28M | -54.63M | -37.31M | -15.48M | -41.69K | -3.52K | -3.52K |
Net Income | -182.11M | -154.1M | -134.04M | -114.93M | -87.5M | -80.89M | -74.28M | -54.63M | -37.31M | -15.48M | -41.69K | -3.52K | -3.52K |
Selling & General & Admin | 36.8M | 28.5M | 24.62M | 21.63M | 9.27M | 7.98M | 7.76M | 5.46M | 3.68M | 2.32M | 41.69K | n/a | 3.52K |
Research & Development | 162.15M | 140.37M | 121.2M | 102.67M | 85.5M | 80.57M | 73.11M | 53.57M | 35.68M | 13.17M | n/a | n/a | n/a |
Other Expenses | -186K | -186K | n/a | n/a | n/a | n/a | n/a | 41.69K | 41.69K | 41.69K | 41.69K | 3.52K | n/a |
Operating Expenses | 198.77M | 168.68M | 145.82M | 124.29M | 94.77M | 88.55M | 80.86M | 59.03M | 39.36M | 15.49M | 41.69K | 3.52K | 3.52K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 198.96M | 168.86M | 145.82M | 124.29M | 94.77M | 88.55M | 80.86M | 59.03M | 39.36M | 15.49M | 41.69K | 3.52K | 3.52K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 80.05K | 31.14M | 31.14M | 23.51M | 23.51M | 23.51M | 16.64M | 23.51M | 23.51M | 22M | 20.49M | 20M | 20.49M |
Shares Outstanding (Diluted) | 80.05K | 31.14M | 31.14M | 23.51M | 23.51M | 23.51M | 16.64M | 23.51M | 23.51M | 22M | 20.49M | 20M | 20.49M |
EPS (Basic) | -709.70 | -5.71 | -5.30 | -3.93 | -2.77 | -1.47 | -0.48 | -0.60 | 0.14 | 0.05 | 0 | 0 | 0 |
EPS (Diluted) | -709.70 | -5.71 | -5.30 | -3.93 | -2.77 | -1.47 | -0.48 | -0.60 | 0.14 | 0.05 | 0 | 0 | 0 |
EBITDA | -194.66M | -168.12M | -145.21M | -123.82M | -94.43M | -88.34M | -80.66M | -58.87M | -39.26M | -15.44M | -41.69K | -3.52K | -3.52K |
EBIT | -195.22M | -168.86M | -145.82M | -124.29M | -94.77M | -88.55M | -80.86M | -59.03M | -39.36M | -15.49M | -41.69K | -3.52K | -3.52K |
Depreciation & Amortization | 561K | 742K | 610K | 468K | 339K | 210K | 208K | 156K | 104K | 52K | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BBOT